Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling-Reference-Cited by-同舟云学术

Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling

Published:2021-10 Issue: Volume:167 Page:104-113
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Merten Hannes,Brandl Fabian,Zimmermann Martina,Schaefer Jonas V.,Irpinio Linda,Sand Kine M.K.,Nilsen Jeannette,Andersen Jan Terje,Zangemeister-Wittke Uwe,Plückthun Andreas

Funder

Research Council of Norway

South-Eastern Norway Regional Health Authority

Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference52 articles.

1. Fusion proteins for half-life extension of biologics as a strategy to make biobetters;Strohl;Biodrugs,2015

2. The neonatal Fc receptor (FcRn): a misnomer?;Pyzik;Front. Immunol.,2019

3. The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery;Bern;J. Control. Release,2015

4. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice;Johansen;J. Exp. Med.,1999

5. Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease;Kitz;Pediatr. Pulmonol.,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically Fused DARPins: A Novel Approach for Designing Extended-Release Thrombopoietin Mimetic Peptides;International Journal of Peptide Research and Therapeutics;2023-08-21

2. Design of a Dual Agonist of Exendin-4 and FGF21 as a Potential Treatment for Type 2 Diabetes Mellitus and Obesity;Iranian Journal of Pharmaceutical Research;2023-08-09

3. Trispecific antibodies for cancer immunotherapy;Immunology;2023-03-08

4. Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies;International Journal of Molecular Sciences;2022-12-28

5. The Regulatory Mechanism of EpCAM N-Glycosylation-Mediated MAPK and PI3K/Akt Pathways on Epithelial-Mesenchymal Transition in Breast Cancer Cells;Cellular and Molecular Biology;2022-05-31